12:00 AM
 | 
Oct 06, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Aranesp darbepoetin alfa hematology data

Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif.
Kirin Brewery Co. Ltd. (Tokyo:2503; Pink:KNBWY), Tokyo, Japan
Product: Aranesp darbepoetin alfa
Business: Hematology
Molecular target: Erythropoietin (EPO) receptor
Description: Erythropoiesis stimulating protein
Indication: Treat anemia
Endpoint: NA
Status: NA
Milestone: NA
Preliminary data from an independent...

Read the full 224 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >